PRODUCTION OF MONOCLONAL-ANTIBODIES AGAINST HUMAN CYTOMEGALOVIRUS
- 1 January 1983
- journal article
- research article
- Vol. 297 (6) , 305-308
Abstract
Cell fusion of Sp2/0, a murine myeloma derived non-secreting variant, with splenic lymphocytes from mice immunized against human cytomegalovirus, has originated 2 stable hybridomas producing monoclonal antibodies (IgG) which react specifically with antigens that appear early in infectious cycle and remain localized in the cell nucleus.This publication has 5 references indexed in Scilit:
- Kinetic study of the development and localization of human cytomegalovirus-induced antigens using monoclonal antibodiesAnnales de l'Institut Pasteur / Virologie, 1983
- Monoclonal antibodies to cytomegalovirus: rapid identification of clinical isolates and preliminary use in diagnosis of cytomegalovirus pneumoniaInfection and Immunity, 1982
- Monoclonal antibodies to human cytomegalovirus: three surface membrane proteins with unique immunological and electrophoretic properties specify cross-reactive determinantsInfection and Immunity, 1982
- Anticomplement immunofluorescence test that uses isolated fibroblast nuclei for detection of antibodies to human cytomegalovirusJournal of Clinical Microbiology, 1980
- Human cytomegalovirus-induced immediate early antigens: analysis in sodium dodecyl sulfate-polyacrylamide gel electrophoresis after immunoprecipitationJournal of Virology, 1979